BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25436494)

  • 1. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY; Medina CA; Aziz HA; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemosurgery for retinoblastoma: what we know after 5 years.
    Abramson DH
    Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy for Malignant Intraocular Tumors.
    Shah CP; Shields CL; Shields JA
    Dev Ophthalmol; 2016; 55():337-43. PubMed ID: 26501748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Chemotherapy Approaches for the Treatment of Intraocular Retinoblastoma: A Comprehensive Review.
    Yuan S; Friedman DL; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):117-128. PubMed ID: 27898618
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative Chemotherapeutic Agents for the Treatment of Retinoblastoma Using the Intra-Arterial and Intravitreal Routes: A Path Forward Toward Drug Discovery.
    Yuan S; Friedman DL; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):129-141. PubMed ID: 27898619
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N; Català-Mora J
    J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
    [No Abstract]   [Full Text] [Related]  

  • 8. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH; Marr BP; Brodie SE; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2014 Aug; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial and oral digoxin therapy for retinoblastoma.
    Patel M; Paulus YM; Gobin YP; Djaballah H; Marr B; Dunkel IJ; Brodie S; Antczak C; Folberg R; Abramson DH
    Ophthalmic Genet; 2011 Sep; 32(3):147-50. PubMed ID: 21446853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
    Shields CL; Lally SE; Leahey AM; Jabbour PM; Caywood EH; Schwendeman R; Shields JA
    Curr Opin Ophthalmol; 2014 Sep; 25(5):374-85. PubMed ID: 25014750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E
    Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal Invasion in Retinoblastoma Treated with Intrarterial Chemotherapy.
    Abramson DH; Francis JH; Gobin YP
    Ophthalmol Retina; 2018 Jan; 2(1):9. PubMed ID: 31047314
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
    Lawson BM; Saktanasate J; Say EA; Shields CL
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity.
    Seregard S; Singh AD
    Br J Ophthalmol; 2012 Apr; 96(4):473-4. PubMed ID: 22421997
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinoblastoma: achieving new standards with methods of chemotherapy.
    Kaliki S; Shields CL
    Indian J Ophthalmol; 2015 Feb; 63(2):103-9. PubMed ID: 25827539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma.
    Santapuram PR; Schremp EA; Friedman DL; Koyama T; Froehler MT; Daniels AB
    Ophthalmol Retina; 2021 Mar; 5(3):309-312. PubMed ID: 32920208
    [No Abstract]   [Full Text] [Related]  

  • 20. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
    Shields CL; Fulco EM; Arias JD; Alarcon C; Pellegrini M; Rishi P; Kaliki S; Bianciotto CG; Shields JA
    Eye (Lond); 2013 Feb; 27(2):253-64. PubMed ID: 22995941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.